
Stephen Otter
Constable
4
APPEARANCES
4
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
Aug 18, 2026
From kings to catalogues: The overlooked asset class with a 600-year history
16:41
25:34

Stephen OtterGUEST
And so I should say, in royalties, there are different stages in all of the sectors.
9 MINS LATER

Ali SelbyHOST
Why now though? Why should people be thinking about royalties at this stage in the market?
Q+A: The $2 trillion asset class most investors overlook
7:23
7:34
7:39
7:48
8:29
10:23
Sean AylmerHOST
so is that one of the big advantages is steady cash flow broadly, investing in royalties? What are the other key advantages of it? And then where does it fit into a portfolio?

Stephen OtterGUEST
Yeah, so we like royalties because where we're investing, we're underwriting purely the yield.

Stephen OtterGUEST
So in every other asset class to generate a return, you're either reliant on interest rates, which we're not, or you're reliant on exits to generate the returns.

Stephen OtterGUEST
We've actually gone one step further, which is we have an IC philosophy where which is if we can't make our target returns on a buy and hold basis only we don't even discuss the investment in the investment committee so we're kind of sat here a little bit agnostic in terms of what's going on in exit markets or interest rates because our returns are just not driven by them we're ultimately trying to provide our investors top line revenue exposure to best in class products which we view as not necessarily being counter cyclical but being very resilient because ultimately whether work is going well or badly you will listen to music whether the markets are going up or down, you will still buy the healthcare treatments you're looking to buy.

Stephen OtterGUEST
The second part of it is because we don't fund costs, we don't suffer from cost inflation.
Sean AylmerHOST
Okay, now we've been talking about the fact that in a sense it's broadly, I was going to say defensive, you may not like that term, but I'm just interested with the different classes, if we think of three, health, commodities and entertainment, when you're talking about investing in musicians like The Weeknd and movies like Dark Knight, Hunger Games, et cetera, which we all know about, do they over the long term have a higher or lower return than commodities vis-a-vis healthcare?
Q+A: The $2 trillion asset class most investors overlook
7:23
7:34
7:39
7:48
8:29
10:23
Sean AylmerHOST
so is that one of the big advantages is steady cash flow broadly, investing in royalties? What are the other key advantages of it? And then where does it fit into a portfolio?

Stephen OtterGUEST
Yeah, so we like royalties because where we're investing, we're underwriting purely the yield.

Stephen OtterGUEST
So in every other asset class to generate a return, you're either reliant on interest rates, which we're not, or you're reliant on exits to generate the returns.

Stephen OtterGUEST
We've actually gone one step further, which is we have an IC philosophy where which is if we can't make our target returns on a buy and hold basis only we don't even discuss the investment in the investment committee so we're kind of sat here a little bit agnostic in terms of what's going on in exit markets or interest rates because our returns are just not driven by them we're ultimately trying to provide our investors top line revenue exposure to best in class products which we view as not necessarily being counter cyclical but being very resilient because ultimately whether work is going well or badly you will listen to music whether the markets are going up or down, you will still buy the healthcare treatments you're looking to buy.

Stephen OtterGUEST
The second part of it is because we don't fund costs, we don't suffer from cost inflation.
Sean AylmerHOST
Okay, now we've been talking about the fact that in a sense it's broadly, I was going to say defensive, you may not like that term, but I'm just interested with the different classes, if we think of three, health, commodities and entertainment, when you're talking about investing in musicians like The Weeknd and movies like Dark Knight, Hunger Games, et cetera, which we all know about, do they over the long term have a higher or lower return than commodities vis-a-vis healthcare?
Meet the Investor Series: Stephen Otter, Partners Group
6:54
7:03
7:12
7:21
18:40

Joey MouracadehHOST
So going back to something you alluded to earlier, why would someone be interested in selling off a future royalty stream?

Stephen OtterGUEST
If you look at the healthcare space, we're typically buying the royalties from the original inventors.

Stephen OtterGUEST
They then enter into a license agreement with a big pharma company who then takes over in terms of the manufacturing, the distribution.

Stephen OtterGUEST
And in return for being allowed to use the IP, they will enter into a license agreement where they will agree a royalty to the original inventor, such that every time the product is sold, the original inventor benefits from the sales.
11 MINS LATER

Joey MouracadehHOST
Where do royalties fit into a typical portfolio that might have large exposures to both those asset classes?